To identify post-translational histone modifications that change in global abundance during this process, we have applied a quantitative mass-spectrometry-based approach. We found that iPSCs, compared with both the starting fibroblasts and a late reprogramming intermediate (pre-iPSCs), are enriched for histone modifications associated with active chromatin, and depleted for marks of transcriptional elongation and a subset of repressive modifications including H3K9me2/me3. Dissecting the contribution of H3K9 methylation to reprogramming, we show that the H3K9 methyltransferases Ehmt1, Ehmt2 and Setdb1 regulate global H3K9me2/me3 levels and that their depletion increases iPSC formation from both fibroblasts and pre-iPSCs. Similarly, we find that inhibition of heterochromatin protein-1γ (Cbx3), a protein known to recognize H3K9 methylation, enhances reprogramming. Genome-wide location analysis revealed that Cbx3 predominantly binds active genes in both pre-iPSCs and pluripotent cells but with a strikingly different distribution: in pre-iPSCs, but not in embryonic stem cells, Cbx3 associates with active transcriptional start sites, suggesting a developmentally regulated role for Cbx3 in transcriptional activation. Despite largely non-overlapping functions and the predominant association of Cbx3 with active transcription, the H3K9 methyltransferases and Cbx3 both inhibit reprogramming by repressing the pluripotency factor Nanog. Together, our findings demonstrate that Cbx3 and H3K9 methylation restrict late reprogramming events, and suggest that a marked change in global chromatin character constitutes an epigenetic roadblock for reprogramming.
Reprogramming of somatic cells into iPSCs by overexpression of the transcription factors Oct4, Sox2, Klf4 and cMyc is a fascinating, but inefficient process, with only a small subset of starting cells converting to a pluripotent state after 1-2 weeks 1,2 . Mechanistic insights into how chromatin regulators and chromatin states control reprogramming are only now beginning to be explored [3] [4] [5] [6] [7] [8] [9] [10] [11] . To gain insight into global chromatin changes that occur during reprogramming to iPSCs, we were interested in quantifying the post-translational modifications (PTMs) of histones. We reasoned that histone PTMs with marked changes in global levels during reprogramming could be important for the suppression or promotion of the process.
Investigations of the role of histone PTMs during reprogramming have typically relied on the use of site-specific histone antibodies in immunostaining and chromatin immunoprecipitation (ChIP) experiments 3, [12] [13] [14] [15] . Although very insightful, these methods are reliant on the availability of cognate antibodies, and epitope recognition can be affected by modifications on neighbouring residues or interacting factors. To circumvent these issues, we used label-free mass spectrometry (qMS)-based proteomics 16, 17 as an alternative approach to quantify alterations in histone PTMs during reprogramming, which is independent of antibodies ( Supplementary Fig. S1A ). Supplementary Table  S1 . (b) Pie charts indicating the percentage of mono-(me1), di-(me2) and tri-(me3) methylated and unmethylated (un) forms of the indicated lysine residues in female iPSCs and MEFs. The unmethylated portion represents the sum of acetylated and unacetylated isoforms. Standard deviations for 6 replicates and significant differences in these PTMs between iPSCs and MEFs are provided in Supplementary Fig. S1B . (c) Log 2 ratio of the percentage of methylated and unmethylated lysines between female MEFs and iPSCs. Histone PTMs that are lower in MEFs than iPSCs are highlighted in green and those that are higher in MEFs than iPSCs in orange. The unmethylated state can be acetylated and/or unacetylated.
(d) Hierarchical clustering of ChIP-chip data for H3K18me1, H3K79me2, RNA polymerase II and H3K4me3 for 18,300 genes. Each row represents the promoter region of a gene spanning −5.5 kb to +2.5 kb relative to the transcriptional start site (TSS), divided into sixteen 500 bp fragments that exhibit the average log ratio of probe signal intensity with blue, yellow and grey representing lower-than-average, higher-than-average and missing values (mostly due to lack of probes in those regions) for enrichment relative to input. (e) The same as in a, except that the combination of PTMs on the histone H3 peptide containing amino acids 9-17 was quantified. Data presented are the mean of 6 mass spectrometry values obtained from 2 biological replicates, each analysed 3 times.The K9 residue was detected in the ac, me1, me2, me3 or the unmethylated/unacetylated (un) forms, and K14 in the ac or un forms. Each combination of histone PTMs on K9 and K14 is referred to as a peptide isoform. Source data are provided in Supplementary Table S1 .
RESULTS

Global levels of many histone PTMs change during reprogramming
To begin with, we determined the abundance of acetylation or methylation modifications at individual lysine residues of histones H3 and H4, at the start and endpoint of reprogramming, that is, in mouse embryonic fibroblasts (MEFs) and iPSCs derived from these cells. Two iPSC and two MEF lines were subjected to six independent qMS reactions per sample (see Methods), generating a highly reproducible quantification of histone PTMs in these cell types, which is summarized in Supplementary Table S1 .
We found a wide variation in the abundance of histone acetylation across lysine (K) residues in both histone H3 and H4. Within histone H3, acetylation was most abundant on residues K14 and K23 irrespective of the cell type analysed (Fig. 1a) . Acetylation of H3K9, a mark associated with transcriptionally active or bivalent promoters and enhancers 18, 19 , of H3K27, a mark characteristic of active enhancers 20 , or of H3K56, which overlaps with the binding of OCT4, SOX2 and NANOG in human embryonic stem cells 21 (ESCs), was present on less than 5% of histone H3 molecules (Fig. 1a) . These results potentially reflect the preferential association of these acetylation events with regulatory genomic elements compared with a broader chromatin role for H3K14 and H3K23ac. For example, H3K14 acetylation has already been implicated in DNA damage responses 22 . Similar variations in the extent of acetylation were found for the lysine residues of the amino-terminal tail of histone H4 (Fig. 1a) . Importantly, almost all acetylated lysines on histone H3 and H4 were more prevalent in iPSCs than MEFs (Fig. 1a) . As acetylation of lysines has been associated with active chromatin states and transcription 18 , our findings extend the conclusion that pluripotent cells are more euchromatic than differentiated cells 23, 24 .
Histone methylation patterns are more complex owing to the presence of mono-, di-and tri-methylation states. As for acetylation, there is a marked variation in the abundance of methylation across lysine residues in MEFs and iPSCs ( Fig. 1b and Supplementary  Fig. S1B ). For methylated lysines related to transcriptional repression, such as H3K9 and H3K27, between 60 and 80% of the respective lysines are methylated in both MEFs and iPSCs, revealing an unexpected coverage of the genome by histones carrying these methylated residues. Methylation at lysine residues known to be associated with enhancers and promoters, for example at H3K4, is much less abundant in both cell types. Surprisingly, methylation associated with transcriptional elongation, particularly H3K36 methylation, is relatively abundant in the genome.
Analysing differences in global histone methylation profiles between iPSCs and MEFs (Fig. 1c) , we found that H3K79me2 and H3K36me3, two methylation marks associated with transcriptional elongation 25, 26 , and the relatively uncharacterized mark H3K18me1 (ref. 27), were the top three marks that are more abundant in MEFs than iPSCs (Fig. 1c) . Notably, the reduction of global levels of H3K79me2 and H3K36me3 during reprogramming may be important for the generation of iPSCs because the inhibition of Dot1L, the enzyme responsible for H3K79 methylation, and overexpression of H3K36me2/me3 demethylases enhance iPSC formation [7] [8] [9] . To better understand the function of H3K18me1, we performed ChIP with an antibody specific for H3K18me1 ( Supplementary Fig. S1C ) in combination with promoter microarrays. We found that H3K18me1 is enriched in coding regions with a pattern similar to that of H3K79me2 (Fig. 1d) . These findings identify the association of a previously uncharacterized histone modification with transcriptional elongation. They also indicate that the most downregulated histone modifications during reprogramming are all linked to transcriptional elongation, which is surprising given that pluripotent cells have been argued to be transcriptionally more permissive compared with differentiated cells 28 . Therefore, these modifications may have different functions in pluripotent and differentiated cells, which will be interesting to study in the future.
Among methylation marks associated with transcriptional silencing, H3K27 methylation states were not very different between iPSCs and MEFs; H3K9me2 and H3K9me3 levels were higher in MEFs than iPSCs; and H4K20me3 and H4K20me1 were more abundant in iPSCs than MEFs (Fig. 1b,c and Supplementary Fig. S1B ). We also noted a strong increase in unmethylated H3K9 and H4K20 residues from MEFs to iPSCs that was higher than that of any methylation mark (Fig. 1c) , suggesting that the unmethylated state of these lysine residues is an important feature of the pluripotent state. Together, these data indicate that not all repressive methylation histone marks are depleted in iPSCs compared with MEFs, although pluripotent cells have a more euchromatic character when compared with MEFs (refs 23,24) . We also conclude that H3K9 and H4K20 methylation, in contrast to H3K27 methylation, may exert effects on reprogramming by modulation of their global levels.
Histones can be modified simultaneously on multiple amino acids. qMS offers arguably the only approach to exactly quantify combinations of PTMs that occur on the same peptide. We therefore examined the combination of acetylation and methylation that occurred within each tryptic histone peptide (that is, in the peptides of H3 containing either K9/K14, K18/K23 or K27/K36, or in the H4 peptide carrying K5/K8/K12/K16; Fig. 1e and Supplementary Fig. S1D-F) . All examined histone peptides accommodate modifications at neighbouring amino acids, highlighting the complex control of histone modifications and functional output. For example, for the H3K9/K14 peptide, we found that repressive K9 methylation marks and the activating K14ac were often present on the same histone molecule (Fig. 1e) . Furthermore, although total levels of H3K14ac were similar between iPSCs and MEFs (Fig. 1a) , H3K14ac was significantly higher in iPSCs than MEFs when H3K9 was unmodified or acetylated on the same histone molecule (Fig. 1e) , indicating that modifications on the K9 residue affect the acetylation status of K14 in a cell-type-specific manner. In addition, the unmodified form of the H3K9/K14 peptide (K9un/K14un) was the most prevalent isoform of this peptide in iPSCs, perhaps enabling the rapid acquisition of various modifications in response to differentiation cues (Fig. 1e) .
A global change in chromatin character occurs late in reprogramming
The differences in global levels of histone PTMs between MEFs and iPSCs prompted us to determine when they occur during reprogramming, and whether iPSCs are similar to ESCs in their global histone PTM profile. Although reprogramming is inefficient, intermediate stages of the process have been described 1, 3, 11, 15, 29, 30 . To examine the global chromatin state in a late intermediate of reprogramming, we took advantage of pre-iPSCs rather than determining histone PTM profiles in heterogeneous reprogramming cultures. These cells can be isolated from reprogramming cultures as a clonal population of cells with an ESC-like morphology that have efficiently repressed the somatic gene expression program but lack the expression of most pluripotency factors 3, 15, 31 . These cells are commonly obtained when reprogramming is induced with retrovirally expressed Oct4, Sox2, Klf4 and cMyc (refs 3,15,31) . We reasoned that the analysis of the histone PTM profile in pre-iPSC lines would allow us to determine when global chromatin character changes occur in the reprogramming process relative to known transcriptional changes. Hence, we performed label-free qMS analysis for histone PTMs on one male ESC line, and one male and one female pre-iPSC line, with at least five replicate qMS data sets per cell line, and compared them with the iPSC and MEF data. Quantitative differences in histone PTMs between two cell types were confirmed directly by using chemical stable isotope labelling and subsequent mixing of the histone samples from the two cell types before MS analysis 17 ( Supplementary Fig. S2 ). Unsupervised hierarchical clustering of histone PTM levels for all replicate data sets, based on combinations of modifications per tryptic histone peptide (summarized in Supplementary Table S1), demonstrated that the global chromatin character of pre-iPSCs is more similar to that of MEFs (Fig. 2a) . Furthermore, pre-iPSCs and MEFs cluster away from both ESCs and iPSCs, which in turn are more related to each other in chromatin state (Fig. 2a) . In pre-iPSCs a few histone PTMs were present at an intermediate level between iPSCs and MEFs, as for instance H3K18ac/K23ac (Fig. 2b) , or less abundant than in any of the other cell lines, as for instance H4K5acK8acK12acK16un (Fig. 2c) . Irrespective of these differences, a shift towards the pluripotency profile is not evident for most histone PTMs in pre-iPSCs. Together these findings demonstrate that ESCs and iPSCs share a similar global histone modification profile revealing a pluripotency-specific global chromatin structure. Furthermore, the transition from the MEF-like Figure 2 Comparison of histone PTM profiles between ESCs, iPSCs, pre-iPSCs and MEFs. (a) Unsupervised hierarchical clustering of the log 2 ratio of the percentage of histone isoforms for each qMS replicate in the indicated cell types relative to the average percentage of the same isoform in female iPSCs. Cell types included are: female iPSCs (fiPSCs, 6 replicates), male iPSCs (miPSCs, 6 replicates), male ESCs (mESCs, 6 replicates), female pre-iPSCs (fpre-iPSCs, 5 replicates), male pre-iPSCs (mpre-iPSCs, 5 replicates), male fibroblasts (mMEFs, 6 replicates) and female fibroblasts (fMEFs, 6 replicates). In the heat map, yellow represents isoforms that are more abundant than in fiPSCs and blue those that are less abundant. For the H4 peptide including amino acids 4-17, 1ac refers to the sum of isoforms that have a single acetylated lysine among K5, K8, K12 or K16; 2ac and 3ac refers to the sum of all isoforms with 2 and 3 acetyl marks, respectively; and 4ac refers to the completely acetylated peptide. to the pluripotency-specific global chromatin character occurs late in reprogramming, after the state represented by pre-iPSCs, rather than gradually throughout the entire reprogramming process. On the basis of these data, we propose that the establishment of the global pluripotency-specific chromatin state may constitute an epigenetic barrier that contributes to the reprogramming block encountered by pre-iPSCs and the low overall efficiency of reprogramming to iPSCs.
H3K9 methylation regulators control the efficiency of reprogramming
Our qMS approach demonstrated that pre-iPSCs and MEFs are more enriched for repressive H3K9 methylation marks than iPSCs. We therefore directed our efforts on further deconvoluting reprogramming barriers associated with the H3K9 site. Specifically, we investigated whether the depletion of the writers, the histone methyltransferase (HMTase) genes Ehmt1, Ehmt2 and Setdb1, or the readers, the heterochromatin protein 1 (HP1) family members Cbx1, Cbx3 and Cbx5, or overexpression of the H3K9 demethylase gene Jmjd2c could modulate the efficiency of reprogramming. HP1 proteins are small proteins that have been shown to bind specifically to methylated histone H3K9 through their chromodomain in biochemical assays 32, 33 . However, although initially identified as evolutionarily conserved regulators of heterochromatin formation, recent progress suggests further roles for HP1 proteins in the regulation of active gene expression in euchromatic regions 34, 35 . As the knockout of some of these genes, such as Setdb1, is known to lead to loss of pluripotency 36, 37 , we only transiently depleted them during reprogramming by means of short interfering RNA (siRNA)-mediated knockdown. Reprogramming was induced by overexpression of Oct4, Sox2 and Klf4, that is, in the absence of ectopic cMyc, in MEFs containing GFP reporters linked to pluripotency promoters (Oct4 or Nanog ). Efficient knockdown for all target genes was confirmed in each reprogramming experiment ( Supplementary Fig.  S3A ). The depletion of any of the three H3K9 HMTases consistently increased the number of Oct4-GFP-positive colonies at least twofold, and simultaneous knockdown of all three HMTases (henceforth called 3XHMT) enhanced reprogramming even more efficiently ( Fig. 3a(i) , Supplementary Fig. S3Ai ). GFP-positive colonies also expressed the endogenous pluripotency marker Esrrb, indicating that the increase in colony number did not simply represent GFP-reporter activation ( Supplementary Fig. S3B ). Depletion of Cbx3 consistently increased the number of Oct4-GFP-positive colonies, whereas the effects of Cbx1 and Cbx5 interference were positive but milder and not always reproducible ( Fig. 3a (ii) and Supplementary Fig. S3Aii ). 3XHMT or Cbx3 knockdown also had a positive effect on reprogramming when cMyc was included as a reprogramming factor, and reprogrammed colonies appeared at least a day earlier than under control conditions, indicating an improvement of the kinetics of the process (Fig. 3b) . In addition, overexpression of Jmjd2c, a H3K9me2/me3 demethylase gene 38 important for the maintenance of the pluripotent state 39 , enhanced reprogramming about twofold ( Fig. 3c and Supplementary  Fig. S3Aiii ). Together, these results extend recent findings that the H3K9 methylation machinery impairs reprogramming to iPSCs and cell-fusion-mediated gain of pluripotency [9] [10] [11] 40 , and indicate that not only the H3K9 methylation enzymes but also members of the HP1 family act as critical barriers of reprogramming. ii. To more directly address whether the reprogramming phenotypes observed above are linked to late reprogramming steps, we next investigated whether pluripotency could be induced in pre-iPSCs by modulating HP1 or H3K9-HMTase levels. Knockdown of any of the three H3K9-HMTases or of any of the HP1 proteins in pre-iPSCs led to an increase in the number of Nanog -GFP-positive cells ( Fig. 4a(i) ). Among the HP1 family members the promoting effect was again most pronounced for Cbx3 depletion (Fig. 4a(i) ). Cbx3 knockdown enhanced the appearance of GFP-positive colonies with an ESC-like morphology to a similar extent as the knockdown of all three H3K9 HMTases together ( Fig. 4a (ii) and Supplementary  Fig. S3C ). However, combined knockdown of Cbx3 and 3XHMT did not enhance colony formation further ( Fig. 4a(ii) ), suggesting that at least some of the events regulated by Cbx3 and the HMTases during reprogramming are overlapping. GFP-positive colonies isolated from the Cbx3-siRNA-treated pre-iPSC cultures were expanded and exhibited high expression levels of pluripotency markers such as Esrrb and Nanog (Fig. 4b) and silencing of the retrovirally encoded Oct4 and Sox2 transgenes ( Supplementary Fig. S3D ), satisfying hallmarks of pluripotency. The finding that decreasing expression levels of Cbx3 or H3K9 HMTases enhance iPSC formation from pre-iPSCs indicates that these proteins constitute a barrier to late reprogramming events. Supplementary Table S2. (b) The same as in a, except that the qMS approach was performed on Cbx3 knockdown.
Functions of H3K9-HMTases and Cbx3 during reprogramming
Next, we performed qMS analysis of histone PTMs in pre-iPSCs three days after initiation of 3XHMT or Cbx3 knockdown to gain insight into the molecular mechanisms of how these regulators promote late reprogramming events (MS data are summarized in Supplementary  Table S2 ). We reasoned that the analysis of histone PTMs shortly after initiation of knockdown but before Nanog -GFP expression was detectable (which first appeared seven days after the introduction of siRNAs ( Supplementary Fig. S3C) ), would reveal direct effects on global chromatin character due to depletion of the factors.
On 3XHMT knockdown, H3K9me2 levels decreased strongly, irrespective of the presence or absence of H3K14 acetylation on the same histone molecule, whereas H3K9me3 decreased only when K14 was acetylated as well (Fig. 5a ), indicating that the 3XHMT knockdown has specific effects in the context of combinatorial histone modifications. The decrease in H3K9me2/me3 was accompanied by a significant gain in the four unmethylated isoforms of the H3K9/K14 peptide: K9un/K14un, K9un/K14ac, K9ac/K14un and K9ac/K14ac (Fig. 5a ). These changes in global chromatin state on the H3K9/K14 peptide trended towards the pattern seen in iPSCs (compare Fig. 5a with Fig. 1e ). With the exception of a few low-abundance histone PTMs, we detected no other marked changes in the histone PTM profile on 3XHMT knockdown (Supplementary Table S2 ), indicating that the PTM state of the H3K9 site does not immediately affect most other histone PTMs. On Cbx3 knockdown most isoforms of the H3K9/K14 peptide did not change significantly in abundance, except those containing H3K9ac with and without K14ac (Fig. 5b) . We conclude that Ehmt1, Ehmt2 and Setdb1, but not Cbx3, directly contribute to the regulation of global H3K9me2/me3 levels in pre-iPSCs, and that a change in global H3K9me levels itself is not sufficient for the induction of pluripotency as additional time in culture is required for the efficient activation of the pluripotency network.
We also performed genome-wide transcriptional profiling on preiPSCs three days after transfection of the siRNAs, to further understand the role of the H3K9-HMTases and Cbx3 in reprogramming. Relatively few genes were differentially expressed in pre-iPSCs depleted for 3XHMT or Cbx3 (3XHMT siRNA: 222 genes 1.5-fold up and 261 genes 1.5-fold down; Cbx3 siRNA: 352 genes 1.5-fold up and 368 genes 1.5-fold down), and about a fifth of the up-and downregulated genes, respectively, changed their expression in the same direction between Cbx3 or 3XHMT knockdown ( Fig. 6a and Supplementary Table S3 ). Further analysis demonstrated that the 3XHMT knockdown drives the gene expression program of pre-iPSCs more strongly towards the iPSC expression pattern than Cbx3 depletion (Fig. 6b) . Accordingly, genes upregulated on 3XHMT knockdown are more highly expressed in pluripotent cells than pre-iPSCs and downregulated genes are expressed at significantly lower levels in pluripotent cells than pre-iPSCs (Fig. 6c) . For the Cbx3 knockdown this trend was seen only for the downregulated genes (Fig. 6c) . Interestingly, the 56 genes downregulated both in the 3XHMT and Cbx3 knockdown included Tgfβ2 and 49 of these genes were also expressed at lower levels in iPSCs than pre-iPSCs (Fig. 6a) , suggesting that the suppression of these genes may be important for the reprogramming enhancement observed on these knockdowns. Consistent with this, TGFβ signalling is already known to inhibit reprogramming 41, 42 . Inspecting the differentially expressed genes for other critical regulators of reprogramming, we found the pluripotency factor Nanog, which has previously been shown to be essential for the final reprogramming stage and to enhance reprogramming when overexpressed 43, 44 , to be among the most upregulated genes in both 3XHMT-and Cbx3-depleted pre-iPSCs ( Fig. 6a,b ; 7-and 10-fold up, respectively). Additional pluripotency factors including Gdf3, Zfp42, Dppa4 and Lin28 were among the upregulated genes in pre-iPSCs specifically on the 3xHMT knockdown ( Fig. 6a and Supplementary  Table S3 ). We conclude that depletion of Cbx3 or 3XHMT yields partially overlapping gene expression changes in pre-iPSCs that converge on the induction of Nanog and the downregulation of genes that become reduced during the transition to the pluripotent state. Our finding that the Cbx3 and 3XHMT knockdowns are not additive in their reprogramming enhancement (Fig. 4b) is consistent with the idea that these knockdowns may enhance iPSC formation through overlapping transcriptional responses.
We therefore explored the contribution of Nanog upregulation to the reprogramming enhancement on 3xHMT or Cbx3 knockdown. As loss-of-function of Nanog prevents the establishment of iPSCs (ref. 43 ), we did not test the consequence of 3XHMT or Cbx3 knockdown in pre-iPSCs lacking Nanog, but instead combined the knockdowns with Nanog overexpression. pre-iPSCs carrying a doxycycline-inducible Nanog transgene were transfected with siRNAs targeting 3XHMT or Cbx3 (Fig. 6d(i) ). Immunostaining indicated that over 90% of the infected cells expressed Nanog on addition of doxycycline, and no expression in the absence of doxycycline (Fig. 6d(ii) ). By itself, overexpression of Nanog resulted in a strong induction of reprogrammed colonies similar to that seen on 3XHMT or Cbx3 knockdown, indicating that high Nanog levels can efficiently convert our pre-iPSCs to iPSCs (Fig. 6d(iii) ). Importantly, the 3XHMT or Cbx3 knockdowns conferred only a further twofold enhancement in iPSC colony formation to Nanog -expressing pre-iPSCs (Fig. 6d(iii) ), consistent with the interpretation that Nanog upregulation is a key downstream event in the enhancement of reprogramming on 3XHMT or Cbx3 depletion.
Nanog is a direct target of Cbx3 in pre-iPSCs
Our data predicted that Nanog is a target of Cbx3 and H3K9 methyltransferases during reprogramming. To this end, we determined the genomic Cbx3 binding sites in pre-iPSCs and ESCs using ChIP-seq (Supplementary Table S4 ). For each cell type, data from two biological replicates were merged for further analysis because they correlated well. We found that Cbx3 occupies regions upstream of the transcriptional start site (TSS) at the repressed Nanog locus in pre-iPSCs, overlapping with known upstream regulatory sites. In ESCs, where Nanog is strongly expressed, Cbx3 binding is absent from these regulatory regions (Fig. 7a) . Given that Nanog is the most upregulated gene on Cbx3 knockdown in pre-iPSCs, these data indicate that Cbx3 directly represses Nanog in pre-iPSCs. Notably, the genomic region upstream of the TSS of Nanog is also enriched for H3K9me3 in pre-iPSCs, partially overlapping with Cbx3 occupancy (Supplementary Fig. S4A ), in agreement with findings that showed H3K9 methylation upstream of the Nanog promoter in differentiating ESCs (ref. 39 ). Together, these findings indicate that Cbx3 functions with H3K9me3 to repress Nanog in the reprogramming process, strengthening our conclusion that Nanog is an important downstream target on which Cbx3 and the regulation of H3K9 methylation converge during reprogramming.
Cbx3 predominantly binds highly expressed genes
Although the Nanog locus is bound by Cbx3 at upstream regulatory regions in pre-iPSCs, genome-wide Cbx3 predominantly occupies genic regions in both pre-iPSCs and ESCs (Fig. 7b) . The number of target genes with significant Cbx3 enrichment was markedly lower in ESCs compared with pre-iPSCs ( Supplementary Fig S4b) , and, across genes, Cbx3 exhibited a distinct binding pattern between these two cell types (Fig. 7c-e) . Specifically, in ESCs, Cbx3 binding within genes increases from the TSS throughout the gene to the 3 end, a pattern consistent with recent reports on Cbx3 binding in cancer cell lines 35 . Most of the target genes of Cbx3 in ESCs are also bound in pre-iPSCs ( Supplementary Fig. S4B ), typically associate with Cbx3 across the gene body (Fig. 7e) , and function in ribosome biogenesis, gene expression and nucleosome assembly based on GO analysis. However, in pre-iPSCs Cbx3 also occupies the TSS regions of a large number of genes (Fig. 7d,e) . Despite the different binding pattern, Cbx3-bound genes are on average expressed at significantly higher levels than their unbound counterparts in both cell types (Fig. 7f) . Grouping Cbx3-bound genes in ESCs and pre-iPSCs into expression tiers also demonstrated that strong gene body and TSS occupancy of Cbx3 favours highly expressed genes ( Supplementary Fig. S4C,D) . On the basis of these findings and published reports 35 , we conclude that Cbx3 typically associates with gene bodies of highly transcribed genes. In addition our data uncover an unexpectedly strong association of Cbx3 with the TSS of expressed genes specifically in pre-iPSCs, which we also observed in early reprogramming intermediates. Table S3 . (b) Expression changes in pre-iPSCs on 3XHMTase or Cbx3 knockdowns in relation to expression in pluripotent cells. The heat map shows the differential expression (log 2 ) for all genes (16, 333) between ESCs, iPSCs, two replicates of the 3XHMT knockdown in pre-iPSCs, and three replicates of Cbx3 knockdown in pre-iPSCs, each relative to control siRNA-transfected pre-iPSCs. Genes are ranked on the basis of average expression differences caused by the 3XHMTase knockdown. Among the most upregulated genes is Nanog. Source data are provided in Supplementary  Table S3 . (c) (i) Box plot of the absolute gene expression levels in ESCs and pre-iPSCs for genes 1.5-fold upregulated on 3XHMT knockdown (left) and Cbx3 knockdown (right) in pre-iPSCs; (ii) for genes 1.5-fold downregulated. Significance of difference in expression was determined by the Wilcoxon test, * P < 0.05, * * * P < 0.01. Source data are provided in Supplementary  Table S3 . ESCs, divided into five groups based on K-means clustering. Blue denotes enrichment in a 100 bp bin normalized to 1 million reads subtracted from normalized input values; values were log 2 transformed. (f) Cbx3-occupied genes are more highly expressed than unbound genes. Box plot of absolute gene expression levels in ESCs and pre-iPSCs for Cbx3-bound and unbound genes. Log 2 expression levels are based on reads per kilobase per million mapped reads (RPKM) from RNA-seq data for these cell types. In this figure, genes were considered bound when Cbx3 was enriched anywhere in a region encompassing 10 kb upstream of the TSS and the coding region. * * * P < 0.01, Wilcoxon test. (g) Distribution of Cbx3-binding sites with respect to distance to the TSS for genes that are up-and downregulated, respectively, in pre-iPSCs on Cbx3 knockdown. All source data for this figure are provided in Supplementary Table S4 .
Despite the widespread binding of Cbx3 to actively transcribed genes in pre-iPSCs only a relatively small number of genes were differentially expressed on Cbx3 depletion (Fig. 6a) . A greater proportion of downregulated than upregulated genes was directly bound by Cbx3 (256 and 196 genes, respectively). Therefore, Cbx3 can both positively and negatively affect its target genes, probably depending on the exact context of its binding. Consistent with this, upregulated genes have slightly more pronounced binding of Cbx3 at the TSS and upstream region than downregulated genes (Fig. 7g ).
Cbx3 associates with the transcriptional initiation complex in a cell-type-and activator-dependent manner
Exploring the nature of the Cbx3 TSS enrichment in pre-iPSCs further, we found that the mediator co-activator complex, which is part of the RNA polymerase II pre-initiation complex (PIC; ref. 45) , mimics the Cbx3-binding pattern at the TSS (Fig. 8a) . The association of Cbx3 with the TSS in pre-iPSCs but not ESCs suggested that Cbx3 and mediator might interact in differentiated cells but not in pluripotent cells. To test this hypothesis, we immunoprecipitated the mediator complex from ESCs and ESC-derived differentiated cells, taking advantage of a tetracycline-inducible transgene encoding a Flag-tagged subunit of mediator (Flag-Med29), and determined whether Cbx3 could be detected in the immunoprecipitate (Fig. 8b) . The results showed that Med29 can co-precipitate Cbx3 much more strongly in differentiated cells than ESCs, indicating that the interaction of mediator and Cbx3 is regulated in a cell-type-dependent fashion. We also studied the recruitment of Cbx3 to the PIC in vitro, employing nuclear extract, the model transcriptional activator GAL4-VP16 and an immobilized GAL4-responsive DNA template. The results show that Cbx3 is recruited from nuclear extracts to the chromatin template, but only on activator addition, as for mediator (Fig. 8c) . These data suggest that Cbx3 is recruited to the TSS of transcribed genes in an activator-dependent manner by associating with the PIC, specifically in differentiated cells. It is conceivable that differential post-translational modifications, the presence of different splice forms of mediator subunits, or a different chromatin composition at the TSS in ESCs versus differentiated cells 46 could explain the cell type specificity of the Cbx3 association with the PIC. As the association of Cbx3 with the TSS in pre-iPSCs seems to occur independently of H3K9me3 ( Supplementary Fig. S4E ), the interaction with PIC components is probably responsible for the Cbx3 recruitment to the TSS. Taken together, our findings reveal a function of Cbx3 in the context of transcriptional regulation at the TSS that seems to be specific for differentiated cells and reprogramming intermediates, as Cbx3 occupancy at the TSS is lacking in pluripotent cells.
DISCUSSION
In summary, our qMS approach has yielded a quantitative and comprehensive analysis of global histone PTMs in differentiated and pluripotent cells, and during reprogramming. Our data indicate that the global histone PTM profile changes late in the reprogramming process, which may be associated with the efficient activation of the pluripotency network, major replication timing changes within early embryonic genes 24 , and the reactivation of the inactive X chromosome 47 . We speculate that global chromatin and replication-timing reorganization are key aspects of the final reprogramming stage, required for establishment of the self-sustaining pluripotency network.
The quantitative repository of global histone modification changes generated here can be used as a starting point for further dissection of reprogramming roadblocks and epigenetic differences between pluripotent and differentiated cells. On the basis of this idea, we determined the role of H3K9 methylation during reprogramming by analysing proteins involved in the regulation of this histone modification. Despite the fact that our work reveals various distinct functions for Cbx3 and the methyltransferase genes Ehmt1, Ehmt2 and Setdb1 during reprogramming, reflected in the differential control of global H3K9 methylation levels or association with the basic transcriptional machinery, the removal of the three H3K9-HMTases or Cbx3 elicited partially overlapping transcriptional responses including the reactivation of the silent Nanog locus late in reprogramming. Our data suggest that these common expression changes cause reprogramming enhancement.
By examining the role of Cbx3, we found a remarkable switch in the location of Cbx3 between pluripotent and non-pluripotent cells, and a physical association of Cbx3 with the mediator complex that could be responsible for targeting Cbx3 to the TSS in non-pluripotent cells. As only a small subset of its target genes become differentially expressed in pre-iPSCs on knockdown of Cbx3, we speculate that Cbx3 binding at the TSS mediates more subtle functions and acts perhaps to maintain or restore nucleosome density near the promoter during transcription to protect the transcribed DNA, or to control aspects of transcriptional elongation. Alternatively, different HP1 family members may also act at the TSS and mask the effects of Cbx3. Consistent with this, another HP1 family member, HP1α, has been shown to localize to the TSS of transcribed genes in Drosophila 48 , suggesting an evolutionarily conserved role of HP1 family members in the PIC. Understanding the mechanistic basis for the switch in Cbx3 localization between pluripotent and non-pluripotent cells will reveal further insight into the nature of the pluripotent state.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Histone sample preparation for quantitative mass spectrometry (qMS). Cell pellets were lysed, nuclei isolated and histones extracted as previously described 17 . For each sample, approximately 100 µg of extracted histones was re-suspended in 30 µl of 100 mM ammonium bicarbonate, at pH 8.0. Chemical propionylation derivatization, digestion and desalting of histones was performed as described previously 27 , except that histones were digested for 6 h. We performed both label-free and isotopically labelled peptide relative quantification. For isotopically labelled peptide comparative MS analysis, d 0 -and d 10 -propionic anhydride were used as previously described 16 . All proteomics data are available at the Stem Cell Omics Repository at http://scor.chem.wisc.edu/.
Mass spectrometry and data analysis. Samples were analysed by LC-MS and MS/MS as described previously 16 . In brief, digested samples were loaded by an Eksigent AS2 autosampler onto 75-µm-ID fused-silica capillary columns packed with 12 cm of C18 reversed-phase resin (Magic C18, 5 µm particles, Michrom BioResources), constructed with an electrospray ionization tip. Peptides were separated by nanoflowLC and introduced into a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer (ThermoElectron), and resolved with a gradient from 5 to 35% buffer B in a 110-min gradient (buffer A: 0.1 M acetic acid; buffer B: 70% acetonitrile in 0.1 M acetic acid) with a flow rate of 150 nl min −1 on an Agilent 1200 binary HPLC system. The Orbitrap was operated in data-dependent mode essentially as previously described 16 . Relative abundances of peptide species were calculated by chromatographic peak integration of full MS scans using an in-house developed computer program. Peptide identity and modifications were verified by manual inspection of MS/MS spectra. Cluster 3.0 was used to create hierarchical clustering of ratio data and Java Treeview for visualization of the output.
Cell lines used for analysis of histone PTMs. The following cell lines were used for histone PTM qMS analysis in Figs 1 and 2: a female iPSC (2D4) line generated by retroviral expression of Oct4, Sox2, cMyc and Klf4 (ref. 13); a male iPSC line (C3) obtained on retroviral expression of Oct4, Sox2 and Klf4 (that is, in the absence of cMyc); a female pre-iPSC line (1A2; ref. 13 ) and a male pre-iPSC line (12-1) both obtained on retroviral expression of Oct4, Sox2, Klf4 and cMyc in Nanog-GFP reporter MEFs. In addition, we used the male ESC line V6.5, and male and female wild-type MEFs from day 13.5 embryos. ESCs, iPSCs and pre-iPSCs were grown in standard mouse ESC media and MEFs in the same media lacking LIF.
Reprogramming experiments.
Reprogramming experiments were carried out from Oct4-GFP (ref. 49) or Nanog GFP (ref. 13) reporter MEFs using pMX retroviruses encoding Oct4, Sox2 and Klf4 as described previously 15 and conducted in media containing 15% serum (FBS). MEFs containing a single polycistronic, tet-inducible cassette carrying the four reprogramming factors Oct4, Sox2, Klf4 and cMyc in the Col1A locus, the tet-transactivator M2rtTA in the R26 locus, and the Oct4-GFP reporter were generated as described previously 50 , and induced to reprogram with 2 µg ml −1 doxycycline. Reprogramming was scored by counting the number of GFP-positive ESC-like colonies at indicated days. All reprogramming experiments from fibroblasts and pre-iPSC experiments were done in biological triplicates, and for each figure, error bars represent standard deviation from two technical replicates of a representative experiment. For pre-iPSC experiments, reprogramming to iPSCs on siRNA knockdown was assessed by counting Nanog-GFP-positive colonies or quantifying GFP-positive cells by FACS at the indicated days. For FACS analysis, 12-1 pre-iPSCs were collected with trypsin, passed through a 40 µm cell strainer to obtain single-cell suspensions and analysed on an LSR cytometer (BD Biosciences). Data were analysed using the FlowJo software (TreeStar). Fuw-tetO-loxp-mNANOG was created by ligationindependent cloning (Infusion, Clontech Mountain View) by digesting the vector Fuw-tetO-loxp-hKLF4 (Addgene 20727) with EcoRI and PCR-amplifying mouse Nanog from pMX-mNANOG (Addgene 13354). The vector was co-transfected with pCMV-delta8.9 and pCAGS-VSVg (gift from D. Kohn, UCLA, USA) into HEK293T cells and viral conditioned media collected 48 h post transfection in serum-free media (Ultraculture, Lonza). Expression was confirmed by immunostaining. For overexpression, Jmjd2c was cloned from a PCR product using gene-specific primers (forward: 5 -ATGCGAATTCATGGAGGTGGTGGAGGTG-3 ; reverse: 5 -ATGCGCGGCCGCCTACTGTCTCTTCTGACA-3 ) into the EcoRI and NotI sites of the pMX vector. Expression was confirmed by quantitative real-time PCR performed with gene-specific primers RNA three days after transduction (forward: 5 -GGCCATGGAAGTAACCTTGA-3 ; reverse: 5 -GAGGCTTACCAAGTGGATGG-3 ). Expression analysis and data processing. To determine the transcriptional changes on 3XHMT and Cbx3 knockdown in pre-iPSCs, total RNA was extracted from the pre-iPSC line 12-1 three days after the cells were subjected to transfection with control siRNAs (in biological triplicates), Cbx3 siRNA (in biological triplicates), or a pool of Ehmt1 siRNA, Ehmt2, siRNA and Setdb1 siRNA (in biological duplicates), and analysed on an Affymetrix GeneChip Mouse Genome 430 2.0 array at the UCLA Clinical Microarray core facility. Quantile normalization was performed using the Affymetrix package (affy) from Bioconductor. To convert probe data into gene expression data, probes ending in _at and _a_at were averaged for each gene. Data at the probe level were normalized with previously published data for ESCs, iPSCs and MEFs (ref. 15) . Data are deposited in the GEO database under GSE44084.
RNA-seq was performed using 4 µg of messenger RNA as starting material from ESCs and pre-IPSCs, using standard Illumina RNA-seq library construction protocols. Briefly, polyadenylated RNA was purified by two rounds of oligo-dT bead selection followed by divalent cation fragmentation under elevated temperature. Following cDNA synthesis with random hexamers, the double-stranded products were end repaired, a single A base was added, and Illumina adaptors were ligated onto the cDNA products. Ligation products with an average size of 300 base pairs (bp) were purified by means of agarose gel electrophoresis. The adaptor-ligated single-stranded complementary DNA was then amplified with 10 cycles of PCR. RNA-seq libraries were sequenced on Illumina HiSeq 2000. The RPKM (reads per kilobase of exon per million) was then computed for each gene.
Med29 immunoprecipitation and PIC capture assay. ESCs expressing
FLAG-Med29 were obtained by targeting 3xFlag-Med29 under the control of a tet-inducible promoter into the ColA1 locus 51 in V6.5 ESCs carrying M2rtTA in the R26 locus. Targeting was confirmed by Southern blotting. Neural precursors were differentiated from these cells after suspension culture of embryoid bodies for four days, and selection in ITSF media for 6 days 52 . Nuclear extracts of ESCs and neural precursors were prepared and the purification of protein complexes containing Med29 was performed as previously described 53 . PIC assembly was performed from HeLa nuclear extract using the immobilized G5E4T and analysed by western blotting as described previously 54 . All primary antibodies were used at 1:1,000 dilution and secondary antibodies at 1:10,000 dilution: anti-FLAG from Sigma (F-1804), anti-Med1(sc-8898) and anti-Cdk8(sc-1521) from SantaCruz; anti-Cbx3 from Millipore; anti-Rbbp5 (Bethyl-A300-109) from Bethyl Labs.
ChIP-seq and ChIP-chip analysis. 12-1 pre-iPSCs or V6.5 ESCs were chemically crosslinked by the addition of formaldehyde to 1% final concentration for 10 min at room temperature, and quenched with 0.125 M final concentration glycine. Cells were washed twice in PBS, re-suspended in sonication buffer (50 mM HEPES, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate and 0.1% SDS), and sonicated with a Diagenode Bioruptor. Cell extracts were incubated with an antibody against Cbx3 (Millipore, 05-690; clone 42s2) or Med1 (sc-8998) overnight at 4 • C and immunoprecipitates were collected with magnetic beads. Beads were washed twice with RIPA buffer, low-salt buffer (20 mM Tris at pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), high-salt buffer (20 mM Tris at pH 8.1, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100 and 0.1% SDS), LiCl buffer (10 mM Tris at pH 8.1, 250 mM LiCl, 1 mM EDTA, 1% deoxycholate and 1% NP-40), and with 1× TE. Reverse crosslinking occurred overnight at 65 • C with 1% SDS and proteinase K. Illumina/Solexa sequence preparation, sequencing and DOI: 10.1038/ncb2768 quality control were performed according to Illumina protocols, with the minor modification of limiting the PCR amplification step to 10 cycles.
Reads were mapped to the mm9 genome using the Bowtie software and only those reads that aligned to a unique position with no more than two sequence mismatches were retained for further analysis. Significant binding events were called as peaks using MACS2.0 using a false discovery rate of 0.05 and the −broadpeaks setting that allows calling of broader domains. Location analysis of called peaks was performed using the Sole-search tool. Visualization of the ChIP-seq signal around the TSS is provided by heat maps generated using Java Treeview. Briefly, enrichment is shown after normalization to 1 million reads and subtraction of normalized input values per 100 bp window. Data are deposited in the GEO database under GSE44242.
For ChIP-chip of H3K18me1 and H3K79me2, chromatin fragments (500 µg) from V6.5 ESCs were enriched with specific antibodies, labelled and hybridized, along with corresponding input fragments, to an Agilent promoter microarray (Agilent-G4490) that contains the promoter regions of 18,300 annotated mouse genes, encompassing regions 5.5 kb upstream to 2.5 kb downstream of the respective TSSs as described previously 15 . The H3K18me1 antibody was generated by N.M., and the H3K79me2 antibody was kindly provided by M. Grunstein at UCLA (USA). The ChIP-chip data sets for H3K4me3 and RNA PolII data have been previously published 5, 15 . Hybridization onto the arrays, washing and scanning were done according to the manufacturer's protocols. Average probe signals were extracted in a 500 bp window-step-wise manner as described previously 15 . Figure S1 Characterization of changes in global histone PTM levels during reprogramming. A) Scheme of the qMS approach. Histones were extracted from nuclei of various cell types and derivatized individually with propionic anhydride, causing a change in mass of 56 daltons. Quantification was performed by LC MS/MS on an orbitrap mass spectrometer. Subsequent analysis of histone PTMs was limited to acetylation and methylation on histone H3 and H4. For each tryptic peptide of H3 and H4, the sum of the observed combinations of acetyl, methyl, or unmethylated/unacetylated PTMs (i.e. isoforms) was set to 100%. B) The graph supports Figure 1B of the main text and shows the percentage of the mono-(me1), di-(me2), trimethylated (me3), and unmethylated forms of the lysines of histone H3 and H4 that exhibit methylation in female iPSCs and MEFs. The unmethylated portion represents the sum of acetylated and unacetylated isoforms (ac/ un). Data presented is the mean of 6 values obtained from 2 biological replicates, each analyzed three times, and error bars represent the standard deviation, based on data presented in Table S1 . Asterisks indicate significant differences between MEFs and iPSCs for the respective isoform, at p<0.01 as determined by the t-test. C) Characterization of the H3K18me1 antibody. A dot-blot containing H3K18me1, H3K9me1, and H3K27me1 peptide spots was incubated with a newly generated polyclonal H3K18me1 antibody to demonstrate the specificity of the antibody raised against H3K18me1 peptide. D) Graph displaying the percentages of all detected isoforms of the histone H3 peptide containing amino acid 18 to 26, in female iPSCs and MEFs. Data presented is the mean of 6 values obtained from 2 biological replicates, each analyzed three times based on data presented in Table S1 . The asterisks indicate significantly different levels between iPSCs and MEFs at p<0.01, as determined by the t-test. Error bars = standard deviation of replicates. In this case, the lysine residues 18 and 23 can be acetylated (ac), methylated, or be in the un-acetylated/un-methylated (un) form. Notably, not all theoretically possible combinations of the modifications on K18
and K23 were found in our mass-spec analysis. Specifically, the K18me1/ K23me1 isoform and the higher degrees of H3K18 or H3K23 methylation were not detected. We found a 3-fold increase of the di-acetylated H3K18ac/ K23ac isoform of the peptide from MEFs to iPSCs, which was greater than that seen for the monoacetylated K18un/K23ac (2-fold) or K18ac/K23un (1.2-fold) isoforms, suggesting co-regulation of these two acetylation marks during reprogramming. E) As in (D), except for the percentages of the all detected isoforms of the histone H3 peptide containing amino acids 27 to 36. This peptide contains the lysine residues 27 and 36 that can be modified. H3K27ac, which is found at active enhancers, is more abundant in iPSCs than MEFs. H3K27me2 and me3, in the absence of acetylation or methylation on K36, are significantly higher in MEFs than iPSCs, but not when in the presence of the methylation marks on K36. F) As in (D), except for the percentages of the all detected isoforms of the histone H4 peptide containing amino acids 4 to 16, which contains the lysine residues 5,8,12, and 16, for which we detected only the acetylation PTM. Acetylation is indicated by "ac" and the unacetylated form by "-". 50% of the peptide was completely unacetylated. Among the mono-acetylated forms of this peptide, the acetylation levels decrease from K16 to K8, followed by K5, and minimal acetylation occurred at K12, with relatively small differences between iPSCs and MEFs. For isoforms containing dual acetylation, the acetylation of both K8 and K16 is as abundant as the isoform that contains acetylation on K8 only, and significantly more prominent in iPSCs than MEFs. Though the triple acetylated isoforms of this peptide are of relatively low abundance, the isoform carrying K8ac, K5ac, and K16ac is almost as abundant as the isoform carrying only K5ac and is significantly more prominent in iPSCs than MEFs. Similarly, the completely acetylated isoform of this peptide is found at higher levels in iPSCs than MEFs. Together, the analysis of the histone PTM isoforms of this peptide suggests co-regulation of specific acetylation PTMs during reprogramming. ii. Figure 3 of the main manuscript. qRT-PCR was performed three days after administering the first siRNA transfection or at the end of the overexpression experiment. For each graph, expression is plotted relative to transcript levels in control siRNA treatments, which was set to 1. Data presented is the mean of three technical replicates from one out of three representative experiments. i) Confirmation of knockdown for the experiment shown in Fig  3Ai. For the 3XHMT knockdown, all three H3K9 HMTases were efficiently knocked down. ii) Confirmation of knockdown for the experiment shown in Fig 3Aii. iii) Confirmation of Jmjd2c overexpression for the experiment shown in Fig 3C. B) Immunostaining analysis of a reprogrammed colony obtained on day 25 of a reprogramming experiment in which Nanog-GFP reporter MEFs were infected with retroviruses expressing the reprogramming factors Oct4, Sox2, and Klf4, and the three H3K9 HMTases were simultaneously knocked down by siRNAs. Shown is an immunostaining for the pluripotency marker Esrrb (red), Nanog-driven GFP-fluorescence (green), and DAPI staining to mark the nuclei (blue). We conclude that reprogrammed colonies do not only exhibit the activation of the Nanog GFP reporter but also of other pluripotency markers. C) Quantification of Nanog-GFP-positive cells from 3XHMT or Cbx3 knockdown in pre-iPSCs carrying the Nanog-GFP reporter by FACS analysis. Data from duplicate experiments is presented. D) Nanog-GFP-positive, ESC-like colonies obtained upon Cbx3 knockdown in pre-iPSCs have silenced the Oct4 and Sox2 retroviruses. Semi-quantitative RT-PCR to determine expression of the retrovirally encoded Oct4 and Sox2 in pre-iPSCs and the iPSC lines Cbx3 #1 and #2 derived from these pre-iPSCs upon Cbx3 knockdown. We conclude that pre-iPSCs but not the iPSCs generated upon Cbx3 knockdown express the reprogramming factor-encoding retroviruses. Fig 8B; i) Flag (Med29); ii) Cbx3; and iii) Med6. E= ESCs and N= ESCderived neural precursors. Note that the membrane was cut before exposing to antibody to save on reagents and samples are derived from the same experiment and that blots were processed in parallel. B) Uncropped images of western blots presented in Fig 8C; i) Cbx3; ii) Med6; iii) Cdk8; and iv) Med1, and Rbbp5. Samples were derived from the same experiment and processed in parallel.
